A practical and evidence-based approach to cardiovascular disease risk reduction.
Implementation of the numerous lifestyle and medical management options for secondary prevention of cardiovascular disease remains a daunting goal for primary care physicians and cardiologists alike. Despite the existence of expert consensus guidelines on cardiovascular prevention by the American College of Cardiology and the American Heart Association, therapies known to improve patient care and decrease morbidity and mortality remain underutilized. This review attempts to simplify cardiovascular risk reduction by summarizing key clinical trials in an "ABC" format. We believe that if health care providers and patients use such a format, important lifestyle and pharmacologic options will more likely be addressed.
Ciccarone Preventive Cardiology Center, Cardiology Division, Department of Medicine, The Johns Hopkins School of Medicine, Baltimore, MD 21287, USA.
Ty J
TJ
Gluckman
Bryan
B
Baranowski
M Dominique
MD
Ashen
Charles A
CA
Henrikson
Marc
M
McAllister
Joel B
JB
Braunstein
Roger S
RS
Blumenthal
D000925:Anticoagulants / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D002784:Cholesterol / Q000097:blood; D003920:Diabetes Mellitus / Q000517:prevention & control; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D008019:Life Style; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D040242:Risk Reduction Behavior
D000925:Anticoagulants; D010975:Platelet Aggregation Inhibitors; D002784:Cholesterol